| The Innovative Medicines Initiative: A European Response to the Innovation Challenge. | |
| | |
MedLine Citation:
|
PMID: 22318619 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The Innovative Medicines Initiative (IMI) was launched in 2008 as a large-scale public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). With a total budget of €2 billion, the IMI aims to boost the development of new medicines across Europe by implementing new collaborative endeavors between large pharmaceutical companies and other key actors in the health-care ecosystem, i.e., academic institutions, small and medium enterprises, patients, and regulatory authorities. Projects conducted by IMI consortia have already delivered meaningful results, providing proof-of-concept evidence for the efficiency of this new model of collaboration. In this article we review recent achievements of the IMI consortia and discuss the growing interest in the IMI as a best-practice model to reinvigorate drug development. |
| | |
Authors:
|
M Goldman |
Related Documents
:
|
5828939 - Bronchiolar emphysema (diffuse bronchiolectasis)--so-called muscular cirrhosis of the l... 22570669 - Integrative laser medicine and high-tech acupuncture at the medical university of graz,... 3567749 - A descriptive study of dairy goat predation in louisiana. 6731619 - Psychological benefits of spiritual baptist "mourning". 22460109 - Defining rewardable innovation in drug therapy. 20856719 - Examining telephone calls in ambulatory oncology. 15505669 - Physician job satisfaction in new zealand versus the united kingdom. 5828939 - Bronchiolar emphysema (diffuse bronchiolectasis)--so-called muscular cirrhosis of the l... 1496729 - The treatment of adult hyperglycaemia in an african rural hospital. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-08 |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: - ISSN: 1532-6535 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Innovative Medicines Initiative, Brussels, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Vo...
Next Document: APEC Harmonization Center: Challenges and Issues Relating to Multiregional Clinical Trials in the AP...